Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders (vol 55, pg 330, 2018)

被引：0
|
作者：
Kocaman, Gulsen [1 ]
Kahraman, Nese [2 ]
Gurkan Koseoglu, Banu [2 ]
Bilgic, Basar [3 ]
Matur, Zeliha [4 ]
Ertas, Mustafa [5 ]
Gulsen, Yesim [3 ]
Baykan, Betul [3 ]
机构：
[1] Bezmialem Vakif Univ, Dept Neurol, Fac Med, Istanbul, Turkey
[2] Istanbul Univ, Istanbul Fac Dent, Dept Maxillofacial Surg, Istanbul, Turkey
[3] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Istanbul, Turkey
[4] Istanbul Bilim Univ, Dept Neurol, Fac Med, Istanbul, Turkey
[5] Private Off, Neurol, Istanbul, Turkey
来源：
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY | 2019年 / 56卷 / 01期
关键词：
D O I：
10.29399/npa.23634
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [41] Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine: A Pooled PREEMPT Analysis
    Diener, Hans-Christoph
    Dodick, David W.
    Lipton, Richard B.
    Sommer, Katherine
    Silberstein, Stephen D.
    NEUROLOGY, 2021, 96 (15)
  • [42] Real-world evidence for chronic migraine control in patients receiving treatment with CGRP mAbs and onabotulinumtoxinA
    Blumenfeld, A.
    Frishberg, B.
    Schim, J.
    Hughes, O.
    Sommer, K.
    Adams, A. Manack
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 152 - 153
  • [43] Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine: A Pooled PREEMPT Analysis
    Diener, Hans-Christoph
    Dodick, David W.
    Lipton, Richard B.
    Sommer, Katherine
    Silberstein, Stephen D.
    TOXICON, 2022, 214 : S15 - S16
  • [44] Effects of OnabotulinumtoxinA Treatment on Disability and Quality of Life in Patients with Chronic Migraine with Baseline Allodynia: A COMPEL Subanalysis
    Young, William B.
    Rothrock, John F.
    Lopez, J. Ivan
    Adams, Aubrey Manack
    Blumenfeld, Andrew M.
    NEUROLOGY, 2018, 90
  • [45] Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine: A Pooled PREEMPT Analysis
    Diener, H. C.
    Dodick, D. W.
    Lipton, R. B.
    Sommer, K.
    Silberstein, S. D.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 155 - 156
  • [46] OnabotulinumtoxinA Treatment Improves Quality of Life in Patients with Chronic Migraine (CM): MSQ Results from PREEMPT
    Silberstein, S. D.
    Varon, S. F.
    Diener, H. -C.
    DeGryse, R. E.
    Turkel, C. C.
    HEADACHE, 2010, 50 : S30 - S31
  • [47] Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine: A Pooled PREEMPT Analysis
    Diener, H. C.
    Dodick, D. W.
    Lipton, R. B.
    Sommer, K.
    Silberstein, S. D.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 105 - 105
  • [48] Epidemiology of chronic and episodic migraine in Europe (vol 19, pg P136, 2018)
    Benhaddi, Hicham
    Fitzgerald, Timothy
    McCabe, Sophie
    Zeidman, Ruth
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [49] HULL PROSPECTIVE ANALYSIS OF ONABOTULINUMTOXINA IN THE TREATMENT OF CHRONIC MIGRAINE; REAL LIFE DATA IN 536 PATIENTS; AN UPDATE
    Ahmed, F.
    Khalil, M.
    Buture, A.
    Nimeri, R.
    CEPHALALGIA, 2016, 36 : 11 - 12
  • [50] LONG-TERM RESULTS OF TREATMENT FOR TEMPOROMANDIBULAR DISORDERS - AN EVALUATION BY PATIENTS
    OKESON, JP
    HAYES, DK
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1986, 112 (04): : 473 - 478
12345